Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$29.88 - $37.04 $322,704 - $400,032
-10,800 Reduced 26.47%
30,000 $1.11 Million
Q4 2021

Feb 15, 2022

BUY
$25.61 - $35.1 $220,246 - $301,860
8,600 Added 26.71%
40,800 $1.24 Million
Q3 2021

Nov 16, 2021

SELL
$33.54 - $40.55 $355,524 - $429,829
-10,600 Reduced 24.77%
32,200 $1.08 Million
Q2 2021

Aug 16, 2021

SELL
$34.54 - $47.25 $400,664 - $548,100
-11,600 Reduced 21.32%
42,800 $1.71 Million
Q1 2021

May 18, 2021

BUY
$42.51 - $63.78 $195,546 - $293,388
4,600 Added 9.24%
54,400 $2.45 Million
Q4 2020

Feb 17, 2021

BUY
$45.3 - $60.27 $751,980 - $1 Million
16,600 Added 50.0%
49,800 $2.82 Million
Q3 2020

Nov 17, 2020

SELL
$47.45 - $62.95 $1.05 Million - $1.39 Million
-22,100 Reduced 39.96%
33,200 $1.58 Million
Q2 2020

Aug 17, 2020

BUY
$46.85 - $61.05 $1.17 Million - $1.52 Million
24,900 Added 81.91%
55,300 $3.26 Million
Q1 2020

May 15, 2020

BUY
$41.6 - $63.4 $1.05 Million - $1.6 Million
25,300 Added 496.08%
30,400 $1.44 Million
Q3 2018

Nov 14, 2018

SELL
$42.88 - $53.7 $227,264 - $284,610
-5,300 Reduced 50.96%
5,100 $263,000
Q4 2017

Feb 15, 2018

BUY
$50.3 - $64.39 $523,119 - $669,656
10,400
10,400 $523,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.